Free Republic

Geert Vanden Bossche, PhDGeert Vanden Bossche, PhD, DVM, is a vaccine research expert. He has a long list of companies and organizations he’s worked with on vaccine discovery and preclinical research, including GSK, Novartis, Solvay Biologicals, and Bill & Melinda Gates Foundation. Dr Vanden Bossche also coordinated the Ebola vaccine program at GAVI (Global Alliance for Vaccines and Immunization).I quoted the text above from this link:Geert Bossche: Halt All Covid-19 Mass Vaccination (Open Letter to WHO) (dryburgh.com)Regarding the video at the FR link:Apparently Del Bigtree who reviews portions of an interview with Vanden Bossche is anti-vax, but the subject of...

As COVID-19 vaccines are being rolled out, an extremely vulnerable group is being overlooked: millions of cancer patients. Doctors nationwide are sounding the alarm that many state governments and the federal advisory committee charged with prioritizing who gets vaccinated should move cancer patients up to the front of the line, right after nursing home residents and frontline health care workers. Right now, they're deemed a lower priority than "essential workers" such as firefighters and mass transit employees. Yet cancer patients are getting decimated by COVID-19. New data from 360 U.S. hospitals show that patients with cancer are more at risk...

It was one week after the terrorist attacks on 9/11 when envelopes containing a white powder began showing up at random locations in four states; among them, a newspaper office in Florida, the Washington D.C. office of then-Senate Majority Leader Tom Daschle, NBC News and the New York Post. The white powder turned out to be anthrax spores, engineered to be readily dispersed and inhaled – a potentially deadly bioterrorism weapon.Anthrax infections are treated with antibiotics. There are two that are most effective; ciprofloxacin and doxycycline.At that time, I was the CEO of a small pharmaceutical company that represented foreign...

SINGAPORE: A new strategy that cripples the ability of the dengue virus to escape the host immune system has been discovered by A*STAR's Singapore Immunology Network (SIgN). The discovery, scientists said, brings hope to what may become the world's first universal dengue vaccine that can give full protection from all four types of the virus. The dengue virus requires the enzyme called MTase, also known as 2'-O-methyltransferase, to chemically modify its genetic material to escape detection. In this study, the researchers discovered that by introducing a genetic mutation to deactivate the MTase enzyme of the virus, initial cells infected by...

NEW YORK The future of vaccines, infectious disease experts say, is teenagers. Parents are used to the idea of their babies getting up to 20 vaccinations by age 2 to prevent polio, measles, chickenpox and other diseases transmitted by coughing. But pharmaceutical companies are inventing new vaccines against diseases usually transmitted by sex, drug use, foreign travel or living in dormitories or barracks. Half a dozen are now in the long and tangled medico-regulatory pipeline between the petri dish and the pediatrician's syringe. "Adolescent vaccines are the next wave," Michael Decker, vice president for scientific affairs at the vaccine subsidiary...